世界卫生组织结核菌/艾滋病病毒双重感染防治政策指南

2012-11-22 WHO 世界卫生组织

  《世界卫生组织结核菌/艾滋病病毒双重感染防治政策指南》是在2004年《TB/HIV防治联合行动暂行政策》基础上修订的。      为了满足各国结核菌/艾滋病病毒双重感染防治工作的迫切需求,2004年WHO出版了《TB/HIV防治联合行动暂行政策》(以下简称《暂行政策》)。当时证据还不充分,所以定义为“暂行政策”。此后,随着《暂行政策》推荐的联合行动在各国大规模实施,从随机对照试验、观察性研

  《世界卫生组织结核菌/艾滋病病毒双重感染防治政策指南》是在2004年《TB/HIV防治联合行动暂行政策》基础上修订的。

  世界卫生组织结核菌/艾滋病病毒双重感染防治政策指南

  为了满足各国结核菌/艾滋病病毒双重感染防治工作的迫切需求,2004年WHO出版了《TB/HIV防治联合行动暂行政策》(以下简称《暂行政策》)。当时证据还不充分,所以定义为“暂行政策”。此后,随着《暂行政策》推荐的联合行动在各国大规模实施,从随机对照试验、观察性研究、应用性研究和最佳实践中产出了大量证据。与此同时,WHO遏制结核病和艾滋病部门也出版了大量结核病和艾滋病防治的指南与政策建议。因此,本次指南修订综合了TB/HIV管理方面的最新证据和WHO建议,供各国结核病规划、艾滋病规划负责人、实施人员和利益攸关方参考使用。

  本指南是目前WHO的TB/HIV防治政策的汇编。沿袭了2004年《暂行政策》的框架,在3个不同的目的下构建活动:建立和加强合作机制;降低HIV/AIDS患者的结核病负担并及早启动抗病毒治疗(3个“I”政策);降低疑似和确诊结核病患者的艾滋病负担。

  与2004年版指南的不同之处为,修订后的指南更加强调建立结核病与艾滋病整合服务机制,且最好是在同一时间和同一地点提供整合的服务。

 指南下载:世界卫生组织结核菌艾滋病病毒双重感染防治政策指南.pdf

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1665294, encodeId=1b3e166529420, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Sat Dec 15 00:28:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253862, encodeId=b533125386231, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260147, encodeId=ef44126014e43, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379338, encodeId=57f613e93383f, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548624, encodeId=ce0e15486249a, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1665294, encodeId=1b3e166529420, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Sat Dec 15 00:28:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253862, encodeId=b533125386231, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260147, encodeId=ef44126014e43, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379338, encodeId=57f613e93383f, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548624, encodeId=ce0e15486249a, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1665294, encodeId=1b3e166529420, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Sat Dec 15 00:28:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253862, encodeId=b533125386231, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260147, encodeId=ef44126014e43, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379338, encodeId=57f613e93383f, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548624, encodeId=ce0e15486249a, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=)]
    2012-11-24 bioon3
  4. [GetPortalCommentsPageByObjectIdResponse(id=1665294, encodeId=1b3e166529420, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Sat Dec 15 00:28:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253862, encodeId=b533125386231, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260147, encodeId=ef44126014e43, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379338, encodeId=57f613e93383f, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548624, encodeId=ce0e15486249a, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1665294, encodeId=1b3e166529420, content=<a href='/topic/show?id=ea3020e82b6' target=_blank style='color:#2F92EE;'>#世界卫生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20782, encryptionId=ea3020e82b6, topicName=世界卫生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=416625942678, createdName=12498e87m47暂无昵称, createdTime=Sat Dec 15 00:28:00 CST 2012, time=2012-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1253862, encodeId=b533125386231, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260147, encodeId=ef44126014e43, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1379338, encodeId=57f613e93383f, content=<a href='/topic/show?id=88a720e859b' target=_blank style='color:#2F92EE;'>#世界卫生组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20785, encryptionId=88a720e859b, topicName=世界卫生组织)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c60d447, createdName=zhenjiu123, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548624, encodeId=ce0e15486249a, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Sat Nov 24 01:28:00 CST 2012, time=2012-11-24, status=1, ipAttribution=)]

相关资讯

山东:艾滋病纳入重点公共场所服务人员体检项目

  山东近日下发通知,将艾滋病纳入重点公共场所服务人员健康体检项目,旨在遏制艾滋病传播。   山东省政府办公厅下发的文件称,近年来山东艾滋病防治工作取得进展,艾滋病监测检测能力提升显著,艾滋病病毒感染者和艾滋病病人的生活质量明显改善,病死率有所下降,艾滋病疫情继续保持低流行状态。但当前艾滋病流行形势依然严峻,山东艾滋病病人每年递增30%左右,艾滋病传播的危险因素广泛持续存在,感染者陆续进入发病期

昂山素季被任命全球艾滋病零歧视倡导者

  2012年11月20日 缅甸议会议员、诺贝尔和平奖得主昂山素季多年来一直是全球抗击艾滋病运动的强有力的支持者。联合国艾滋病毒/艾滋病联合规划署11月20日宣布,正式任命昂山素季为全球艾滋病零歧视倡导者。  缅甸议会议员、诺贝尔和平奖得主昂山素季前不久在缅甸首都内比都与联合国艾滋病规划署执行主任西迪贝(Michel Sidibé)会面时接受了这一称号,并表示这是一个莫大的荣誉,她要为维护挣扎在社

卫生部发布2012年“世界艾滋病日”宣传活动通知

  10月31日,卫生部发布了防治艾滋病宣传活动通知。2012年12月1日是第25个“世界艾滋病日”。为进一步贯彻落实《国务院关于进一步加强艾滋病防治工作的通知》和《中国遏制与防治艾滋病“十二五”行动计划》,切实推进艾滋病防治工作,卫生部决定在12月1日前后开展系列宣传活动。   通知指出,今年活动主题为“行动起来,向‘零’艾滋迈进”(英文主题Getting to Zero)

加拿大艾滋病疫苗临床试验首阶段成功

  加拿大西安大略大学研究人员6日宣布,他们研制的艾滋病疫苗在第一阶段的人体临床试验中获得成功,研究人员认为,这是朝艾滋病疫苗临床实用迈进的重要一步。   去年底,该疫苗获批在美国开展人体试验,研究人员今年3月正式在美国开始试验。受试人群是年龄介于18岁~50岁的艾滋病病毒感染者,他们被随机分成两组,一组注射新型疫苗,另一组注射安慰剂。   研究人员表示,注射新型疫苗的受试者至今没有出现副作用

IJV:我国艾滋病疫苗研究有新进展

  中国科学院广州生物医药与健康研究院研究人员,利用新技术,在恒河猴模型上进行了腺病毒载体艾滋病疫苗试验,去除了血液中的中和抗体等其他可能影响腺病毒感染效果的因素,使疫苗可在体内更有效地发挥特定的生物学功能。相关研究成果已发表于国际期刊《病毒学杂志》上。   腺病毒,尤其是人5型腺病毒(Ad5)已被广泛作为重组基因治疗和疫苗载体,最新数据表明,全球约有1/4的基因治疗和疫苗载体的临床试验应用了A

JBC:可中和九成艾滋病毒菌株某一抗体作用机理

  来自清华大学,艾滋病研究中心的长江特聘教授张林琦是著名旅美中国学者、美国洛克菲勒大学艾伦·戴蒙德艾滋病研究中心首席华裔科学家,近期其研究组在JBC杂志上发表文章,解析了对于一种新发现,能中和高达90%的艾滋病病毒菌株的抗体,出现耐药性病毒菌株的作用机理,指出了其中V5区的一个单残基在其中扮演的关键角色,这将有助于提高这一新型抗体在艾滋病治疗中的作用。   艾滋病令人望而生畏,据《2011年中